Lv0
0 积分 2025-08-20 加入
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study
22天前
已完结
Mavacamten: a novel small molecule modulator of β-cardiac myosin for treatment of hypertrophic cardiomyopathy
22天前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
22天前
已完结
Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation
25天前
已完结
Hypertrophic cardiomyopathy or athlete's heart? A systematic review of novel cardiovascular magnetic resonance imaging parameters
25天前
已完结
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy
26天前
已完结
Hypertrophic Cardiomyopathy and Exercise
27天前
已关闭
New Insights and Recommendations for Athletes With Hypertrophic Cardiomyopathy
27天前
已完结
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
28天前
已完结
Acute Predictors of Subacute Complete Heart Block After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
28天前
已完结
皖公网安备34019202002308
